Features that define clinical severity of ulcerative pyoderma gangrenosum: a Delphi consensus study of experts and patients on behalf of the US Medical Dermatology Society.
作者信息
Pimentel Matthew A, Li May M, Noe Megan H, Latour Emile, Seminario-Vidal Lucia, Greiling Teri, Shinkai Kanade, Hamilton Andrew, Alavi Afsaneh, Bolognia Jean L, Cowen Edward W, Dominguez Arturo, Fernandez Anthony P, Fivenson David, Huang William W, Madigan Lauren M, Mauskar Melissa, Means Alexander D, Nelson Caroline A, Patsatsi Aikaterini, Pugliese Douglas, Rojek Nathan W, Rosenbach Misha, Smith Gideon P, Swerlick Robert A, Heffernan Michael P, Mostaghimi Arash, Ortega-Loayza Alex G
机构信息
Department of Dermatology, Oregon Health and Science University, Portland, OR, USA.
出版信息
Br J Dermatol. 2023 Mar 30;188(4):566-568. doi: 10.1093/bjd/ljac137.
Abstract
摘要
相似文献
1
Features that define clinical severity of ulcerative pyoderma gangrenosum: a Delphi consensus study of experts and patients on behalf of the US Medical Dermatology Society.定义溃疡性坏疽性脓皮病临床严重程度的特征：一项代表美国医学皮肤病学会的专家和患者德尔菲共识研究。
Br J Dermatol. 2023 Mar 30;188(4):566-568. doi: 10.1093/bjd/ljac137.
2
Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum in Clinical Trials: A Delphi Consensus on Behalf of the UPGRADE (Understanding Pyoderma Gangrenosum: Review and Assessment of Disease Effects) Group.临床试验中活动性坏疽性脓皮病的入选标准：UPGRADE（了解坏疽性脓皮病：疾病影响的回顾和评估）小组的德尔菲共识。
J Invest Dermatol. 2024 Jun;144(6):1295-1300.e6. doi: 10.1016/j.jid.2023.12.006. Epub 2023 Dec 16.
3
Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts.溃疡性坏疽性脓皮病的诊断标准：国际专家德尔菲共识。
JAMA Dermatol. 2018 Apr 1;154(4):461-466. doi: 10.1001/jamadermatol.2017.5980.
4
[Pyoderma gangrenosum: a report of 15 cases and review of the literature].[坏疽性脓皮病：15例报告及文献复习]
Actas Dermosifiliogr. 2012 Mar;103(2):120-6. doi: 10.1016/j.ad.2011.04.010. Epub 2011 Jul 22.
5
PYODERMA GANGRENOSUM AS THE ONLY MANIFESTATION OF ASYMPTOMATIC NEWLY DIAGNOSED NONSPECIFIC ULCERATIVE COLITIS. CLINICAL CASE.坏疽性脓皮病作为无症状初诊非特异性溃疡性结肠炎的唯一表现。临床病例。
Wiad Lek. 2022;75(10):2549-2553. doi: 10.36740/WLek202210144.
6
[Ulcerative colitis associated with pyoderma gangrenosum].[溃疡性结肠炎合并坏疽性脓皮病]
Orv Hetil. 1994 Apr 24;135(17):917-9.
7
Pyoderma gangrenosum refined elements for core item selection and evaluation (PRECISE-PG): a study protocol for reaching consensus on core outcome domain items in clinical trials of pyoderma gangrenosum.坏疽性脓皮病核心项目选择与评估的精炼要素（PRECISE-PG）：一项关于坏疽性脓皮病临床试验核心结局领域项目达成共识的研究方案
Arch Dermatol Res. 2025 Feb 20;317(1):449. doi: 10.1007/s00403-025-03920-w.
8
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.与溃疡性结肠炎相关的泛发性坏疽性脓皮病：英夫利昔单抗和硫唑嘌呤治疗成功
Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5.
9
Pyoderma gangrenosum and ulcerative colitis in the tropics.热带地区的坏疽性脓皮病与溃疡性结肠炎
Rev Soc Bras Med Trop. 2008 Nov-Dec;41(6):664-7. doi: 10.1590/s0037-86822008000600020.
10
Minimum data set for treatment effectiveness in pyoderma gangrenosum (MIDSTEP): an international protocol of an e-Delphi study to develop a clinical physician-driven treatment effectiveness registry on behalf of the UPGRADE initiative.坏疽性脓皮病治疗效果最小数据集（MIDSTEP）：一项国际电子德尔菲研究协议，旨在代表 UPGRADE 倡议开发一个由临床医生驱动的治疗效果登记处。
Arch Dermatol Res. 2023 Dec;315(10):2913-2919. doi: 10.1007/s00403-023-02729-9. Epub 2023 Sep 27.
引用本文的文献
1
An approach to diagnosis and management of patients with pyoderma gangrenosum from an international perspective: results from an expert forum.从国际视角看坏疽性脓皮病患者的诊断与管理方法：专家论坛结果
Arch Dermatol Res. 2024 Feb 24;316(3):89. doi: 10.1007/s00403-024-02829-0.
2
Pyoderma Gangrenosum: Treatment Options.坏疽性脓皮病：治疗选择。
Drugs. 2023 Sep;83(14):1255-1267. doi: 10.1007/s40265-023-01931-3. Epub 2023 Aug 23.
3
Multilesional pyoderma gangrenosum is associated with longer healing times and higher rates of underlying comorbidities: A single-center prospective registry study.多病灶坏疽性脓皮病与更长的愈合时间及更高的潜在合并症发生率相关：一项单中心前瞻性登记研究。
JAAD Int. 2023 May 27;12:133-135. doi: 10.1016/j.jdin.2023.05.009. eCollection 2023 Sep.
本文引用的文献
1
Pyoderma gangrenosum study pilot registry: The first step to a better understanding.坏疽性脓皮病研究试点登记：迈向更好理解的第一步。
Wound Repair Regen. 2022 May;30(3):334-337. doi: 10.1111/wrr.13005. Epub 2022 Apr 1.
2
Health-related domains of quality of life in pyoderma gangrenosum: A qualitative analysis.坏疽性脓皮病患者生活质量的健康相关领域：一项定性分析。
J Am Acad Dermatol. 2022 Jun;86(6):1382-1385. doi: 10.1016/j.jaad.2021.05.040. Epub 2021 May 29.
3
Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults.皮肤科住院医师协会关于成人史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症管理的支持性护理指南。
J Am Acad Dermatol. 2020 Jun;82(6):1553-1567. doi: 10.1016/j.jaad.2020.02.066. Epub 2020 Mar 7.
4
Extracutaneous involvement of pyoderma gangrenosum.坏疽性脓皮病的皮肤外表现。
Arch Dermatol Res. 2019 Aug;311(6):425-434. doi: 10.1007/s00403-019-01912-1. Epub 2019 Mar 29.
5
Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum: A Delphi Consensus of International Experts.溃疡性坏疽性脓皮病的诊断标准：国际专家德尔菲共识。
JAMA Dermatol. 2018 Apr 1;154(4):461-466. doi: 10.1001/jamadermatol.2017.5980.
6
The Association of Age With Clinical Presentation and Comorbidities of Pyoderma Gangrenosum.年龄与坏疽性脓皮病临床表现和合并症的关系。
JAMA Dermatol. 2018 Apr 1;154(4):409-413. doi: 10.1001/jamadermatol.2017.5978.
7
The PARACELSUS score: a novel diagnostic tool for pyoderma gangrenosum.PARACELSUS 评分：一种用于坏疽性脓皮病的新型诊断工具。
Br J Dermatol. 2019 Mar;180(3):615-620. doi: 10.1111/bjd.16401. Epub 2018 May 6.
8
International multispecialty consensus on how to evaluate ultrasound competence: a Delphi consensus survey.国际多学科超声能力评估共识：德尔菲共识调查。
PLoS One. 2013;8(2):e57687. doi: 10.1371/journal.pone.0057687. Epub 2013 Feb 28.
Zotero 插件